US Patent Issued to Halozyme on Feb. 10 for "Hyaluronidase enzyme formulations for high volume administration" (California Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,429, issued on Feb. 10, was assigned to Halozyme Inc. (San Diego).

"Hyaluronidase enzyme formulations for high volume administration" was invented by David W. Kang (San Diego), Robert J. Connor (San Diego), Tara Nekoroski (San Diego), Todd J. Leadens II (San Diego), Baylor Frantz (San Diego), Scott Beacher (San Diego), Kevin Swanson (San Diego) and Mike Travanty (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "In one aspect, the present disclosure provides a formulation comprising a hyaluronidase enzyme and a therapeutically effective amount of an active ingredient. In another aspect, the present disclosure provides a method of administerin...